restenosis

(redirected from Coronary restenosis)
Also found in: Medical.
Translations

re·ste·no·sis

n. reestenosis, recurrencia de estenosis después de cirugía correctiva.

restenosis

n reestenosis f
References in periodicals archive ?
(2013) Regular exercise training reduces coronary restenosis after percutaneous coronary intervention in patients with acute myocardial infarction.
Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis
Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model.
Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
de Bruyne et al., "Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty.
Radiation-Induced Coronary Artery Disease and Its Treatment: A Quick Review of Current Evidence
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimuseluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation.
Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease
Postmus et al., "Systematic testing of literature reported genetic variation associated with coronary restenosis: Results of The GENDER Study," PLOS ONE, vol.
Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent
Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation, 2001; 103:2289-2295.
Keratin as a novel drug carrier for drug coated balloons
Coronary stents provide a path to the blood flow in the blocked coronary arteries in patients suffering from the condition of coronary restenosis.
Healthcare Industry : The US Coronary Stent Industry Research Report
Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis. Expert Rev Cardiovasc Ther 2004; 2: 653-60.
Drug eluting stents: current status and new developments/ Ilac kapli stentler: mevcut durum ve yeni gelismeler
A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med., 348, 1537-1545 (2003).
New generation sirolimus eluting PTCA angioplasty balloon catheter for restenosis therapy
Patients who have had previous percutaneous coronary interventions are potentially at significant perioperative risk, as a result of haemorrhage (secondary to anti-platelet medication), thrombosis and myocardial infarction (associated with withdrawal of anti-platelet (thienopyridine) therapy) and late coronary restenosis. Perioperative considerations in these patients are presented in Table VIII.
Cardiovascular disease is common in South Africa, and anaesthesia is commonly required in these patients
Angiographically significant coronary restenosis was considered present if clinical symptoms persisted and coronary angiography showed lumen narrowing [greater than or equal to] 50%, as measured by quantitative coronary angiography (Quantcor; Siemens).
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-I gene promoter polymorphism and the heme oxygenase-I + 99G/C variant
Dictionary browser ?
Full browser ?